ABI-007
Showing 26 - 50 of 559
Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7
Completed
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7
- +8 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (Atezolizumab,
Active, not recruiting
- Breast Adenocarcinoma
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2021
Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC
Active, not recruiting
- Resectable Cholangiocarcinoma
- +5 more
- Cisplatin
- +2 more
-
Atlanta, Georgia
- +6 more
Oct 5, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Carcinoma, Transitional Cell Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1, Gemcitabine, cisplatin)
Completed
- Carcinoma, Transitional Cell
- nanoparticle albumin-bound paclitaxel, S-1
- Gemcitabine, cisplatin
-
Beijing, ChinaChinese PLA General Hospital
Aug 5, 2021
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Adavosertib
- +5 more
-
Chicago, Illinois
- +4 more
Jun 10, 2021
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in United States (Laboratory Biomarker Analysis, Paclitaxel
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer
- Laboratory Biomarker Analysis
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
-
Anchorage, Alaska
- +11 more
Jun 26, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Carboplatin
- +6 more
-
Orange, California
- +15 more
Aug 23, 2022
Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or
Active, not recruiting
- Melanoma
- +8 more
- Pegilodecakin
- +9 more
-
Los Angeles, California
- +9 more
Nov 15, 2022
Breast Cancer Trial in Washington (capecitabine, paclitaxel albumin-stabilized nanoparticle formulation, neoadjuvant therapy)
Withdrawn
- Breast Cancer
- capecitabine
- +2 more
-
Washington, District of ColumbiaWashington Cancer Institute at Washington Hospital Center
Feb 15, 2021
Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Not yet recruiting
- Stage III Lung Cancer AJCC v8
- +6 more
- Carboplatin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
May 14, 2021
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Columbus (Gemcitabine, Nab-paclitaxel)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 15, 2020
Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- carboplatin
- +2 more
-
Duarte, California
- +1 more
Jul 9, 2021
NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- nab-paclitaxel IV
- +2 more
-
San Francisco, California
- +33 more
Jan 24, 2022
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Fluorouracil
- +8 more
-
Boise, Idaho
- +42 more
Jun 8, 2022
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Metastatic Breast Cancer Trial in Kiev (ABI-007, Docetaxel)
Completed
- Metastatic Breast Cancer
- ABI-007
- Docetaxel
-
Kiev, UkraineStudy Sites in Russia and the Ukraine
Nov 7, 2019
NSCLC (NSCLC) Trial in St. Petersburg (ABI-007 (Abraxane) and Carboplatin)
Completed
- Non-Small Cell Lung Cancer (NSCLC)
- ABI-007 (Abraxane) and Carboplatin
-
St. Petersburg, Saint Petersburg, Russian FederationStudy Sites in Russia
Nov 7, 2019
Angina Pectoris, Coronary Artery Disease Trial in Durham (Paclitaxel Nanoparticle Albumin Bound)
Completed
- Angina Pectoris
- Coronary Artery Disease
- Paclitaxel Nanoparticle Albumin Bound
-
Durham, North CarolinaAbraxis BioScience, Inc.
Nov 14, 2019